| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00811018 Details | 2012-04-24 Interventional | 3 | 1192 | Sitaxsentan Familial Primar… Hypertension Pulmonary Arter… | This trial was prematurely terminated on Dec 9 2010 due to safety concerns, specifically
emerging evidence of hepatic injury. Mean and dispersion for clinical abnormalities were intended to be reported but due to early termination of study (09-Dec-2010) only number and percent of participants are available. | |||
| NCT01296698 Details | 2012-04-23 Interventional | 3 | 257 | Nicotine Tobacco Use Dis… Tobacco Depende… | Study terminated due to a technical issue (randomization error). Summary tabulations are not available for the primary and some secondary outcome measures because the study was terminated early due to a technical issue (randomization error). | |||
| NCT00499889 Details | 2012-04-23 Interventional | 2 | 42 | Antilymphocyte … Busulfan Fludarabine Fludarabine pho… Imatinib Mesyla… Methotrexate Tacrolimus Thymoglobulin Vidarabine Leukemia | Support issue. Study completed early due to support issues. | |||
| NCT00337740 Details | 2012-04-23 Interventional | 3 | - | Propranolol Esophageal and … Liver Cirrhosis Esophageal Vari… | From the interim analysis resulted that more than 1000 patients were required to demonstrate a
significant difference between the 2 treatments. - | |||
| NCT00771706 Details | 2012-04-20 Interventional | 3 | 0 | Proton Pump Inh… Chronic Cough Cough Esophagitis, Pe… Gastroesophagea… | This study was not activated, no data was collected. - | |||
| NCT00414024 Details | 2012-04-20 Interventional | 3 | 11 | Tegaserod Constipation Opioid-Induced … Opioid-induced … | This study was terminated early as a result of regulatory action suspending tegaserod use in
2007 - | |||
| NCT00365820 Details | 2012-04-20 Interventional | 2/3 | - | Tegaserod Constipation Opioid-Induced … | This study was terminated early as a result of regulatory action suspending tegaserod use in
2007 - | |||
| NCT00241046 Details | 2012-04-19 Interventional | 4 | 13 | Letrozole Breast Neoplasm… Metastatic Brea… | - - | |||
| NCT01082718 Details | 2012-04-13 Interventional | 2/3 | 0 | Artesunate Mefloquine Malaria Pregnancy | Logistical difficulties - | |||
| NCT00248131 Details | 2012-04-10 Interventional | 3 | - | Octreotide Diabetic Retino… Retinal Disease… | - - | |||
| NCT00113971 Details | 2012-04-03 Interventional | 2 | - | Epratuzumab Lupus Erythemat… | - - | |||
| NCT00437359 Details | 2012-03-30 Interventional | 2 | - | Anastrozole Toremifene Breast Neoplasm… | - - | |||
| NCT00138229 NCT00118599 Details | 2012-03-29 Interventional | 2 | 6 | Aldesleukin Cyclophosphamid… Fludarabine Fludarabine pho… Melanoma Melanoma (Skin) | - - | |||
| NCT01102218 Details | 2012-03-28 Interventional | 2 | 48 | Epoetin Alfa Pentoxifylline Anemia Kidney Diseases Kidney Failure,… End Stage Renal… | Lack of statistical difference between both arms of the trial. Release of new FDA guidelines re target Hgb values impacted EPO dosing. | |||
| NCT00854230 Details | 2012-03-28 Interventional | 4 | 0 | Naltrexone Acquired Immuno… Alcohol-Related… Communicable Di… HIV Infections Infections HIV Infection Heavy Alcoholic… | We expanded to a bigger, multi-site study & decided to close this study. - | |||
| NCT00820924 Details | 2012-03-28 Interventional | 2 | 23 | Lapatinib Breast Neoplasm… Neoplastic Cell… Neoplasms, Brea… | - - | |||
| NCT00495625 Details | 2012-03-27 Interventional | 2 | 33 | Sunitinib Carcinoma, Hepa… Liver Neoplasms Liver Cancer | - The Principal Investigator who initiated the study left Moffitt before reaching the target enrollment required to perform the planned analysis. | |||
| NCT01445587 Details | 2012-03-26 Interventional | 2 | 0 | Bortezomib Multiple Myelom… Neoplasms, Plas… Cancer | Based on the clinical activity, not safety data, of the AKT inhibitor, GSK has decided at this
time to suspend further development of GSK2110183 as monotherapy. - | |||
| NCT01367990 Details | 2012-03-23 Interventional | 1 | 3 | Norepinephrine Alopecia Alopecia Areata Head and Neck N… Radiodermatitis | Study site has terminated the study due to the complexity of the study - | |||
| NCT00827099 Details | 2012-03-23 Interventional | 2 | 5 | Antilymphocyte … Fludarabine Fludarabine pho… Melphalan Mycophenolic Ac… Tacrolimus Leukemia Lymphoma Multiple Myelom… Myelodysplastic… Myeloproliferat… Neoplasms, Plas… Plasmacytoma Preleukemia Syndrome Multiple Myelom… | Unacceptable morbidity & mortality This study was terminated early, therefore no additional data measures or outcomes are available. |